Mercury Biopharmaceutical Corporation (TPEX:6932)

Revenue by Product

Financials in millions TWD. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022
Pharmaceutical	1.03M	Log In
Pharmaceutical Growth	-61.46%	Log In

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022
Singapore	1.03M	Log In
Taiwan	-	Log In
United States	-	Log In